ClinConnect ClinConnect Logo
Search / Trial NCT06563674

Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis

Launched by CHINESE UNIVERSITY OF HONG KONG · Aug 20, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pneumoconiosis Healthy Lifestyle Acceptance Based

ClinConnect Summary

This clinical trial is looking at a program designed to help patients with pneumoconiosis, a lung condition that often causes symptoms like coughing and shortness of breath. The goal is to see if an educational program that encourages acceptance of their condition can help patients manage their symptoms better and improve their overall well-being. The study will involve 80 participants who will be divided into two groups: one will start the program right away, while the other will wait for six weeks before participating. The program includes four sessions that focus on both acceptance techniques and caring for their lung health. Researchers will check in with participants at the start, after six weeks, and again after 14 weeks to see how they are doing.

To be eligible for the trial, participants must be ethnic Chinese adults aged 18 or older who are currently receiving compensation for their pneumoconiosis. However, individuals with certain mental or sensory impairments, or those unable to provide written consent, will not be able to join. This study aims to explore new ways to support people with pneumoconiosis and could lead to better management strategies for this condition and other chronic lung diseases in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Ethnic Chinese who is able read and speak Chinese.
  • 2. Adults aged 18 or over.
  • 3. Taking compensation for pneumoconiosis.
  • Exclusion Criteria:
  • 1. Those who have mental, visual, hearing, or cognitive impairments with regular medical follow-ups and treatment.
  • 2. Those who are unable to give written consent.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported